Scope of the Report:

The worldwide market for Anti-inflammatory Therapeutics is expected to grow at a CAGR of roughly over the next five years, will reach million US$ in 2024, from million US$ in 2019, according to a new study.

This report focuses on the Anti-inflammatory Therapeutics in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers, this report covers

AbbVie Inc.

Pfizer Inc.

Merck & Co., Inc.

Johnson & Johnson

GlaxoSmithKline plc

AstraZeneca PLC

Amgen Inc

Novartis AG

F. Hoffmann-La Roche AG

Eli Lily and Company

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia etc.)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

Nonsteroidal Anti-inflammatory Diseases (NSAIDs)

Immune Selective Anti-inflammatory Derivatives (ImSAIDs)

Corticosteroids

Biologics

Market Segment by Applications, can be divided into

Arthritis

Psoriasis

Respiratory Disease

Multiple Sclerosis

Inflammatory Bowel Disease

Other Inflammatory Disease

The content of the study subjects, includes a total of 15 chapters:

Chapter 1, to describe Anti-inflammatory Therapeutics product scope, market overview, market opportunities, market driving force and market risks.

Chapter 2, to profile the top manufacturers of Anti-inflammatory Therapeutics, with price, sales, revenue and global market share of Anti-inflammatory Therapeutics in 2017 and 2018.

Chapter 3, the Anti-inflammatory Therapeutics competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the Anti-inflammatory Therapeutics breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.

Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.

Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.

Chapter 12, Anti-inflammatory Therapeutics market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.

Chapter 13, 14 and 15, to describe Anti-inflammatory Therapeutics sales channel, distributors, customers, research findings and conclusion, appendix and data source.

Table of Contents

1 Market Overview

1.1 Anti-inflammatory Therapeutics Introduction

1.2 Market Analysis by Type

1.2.1 Nonsteroidal Anti-inflammatory Diseases (NSAIDs)

1.2.2 Immune Selective Anti-inflammatory Derivatives (ImSAIDs)

1.2.3 Corticosteroids

1.2.4 Biologics

1.3 Market Analysis by Applications

1.3.1 Arthritis

1.3.2 Psoriasis

1.3.3 Respiratory Disease

1.3.4 Multiple Sclerosis

1.3.5 Inflammatory Bowel Disease

1.3.6 Other Inflammatory Disease

1.4 Market Analysis by Regions

1.4.1 North America (United States, Canada and Mexico)

1.4.1.1 United States Market States and Outlook (2014-2024)

1.4.1.2 Canada Market States and Outlook (2014-2024)

1.4.1.3 Mexico Market States and Outlook (2014-2024)

1.4.2 Europe (Germany, France, UK, Russia and Italy)

1.4.2.1 Germany Market States and Outlook (2014-2024)

1.4.2.2 France Market States and Outlook (2014-2024)

1.4.2.3 UK Market States and Outlook (2014-2024)

1.4.2.4 Russia Market States and Outlook (2014-2024)

1.4.2.5 Italy Market States and Outlook (2014-2024)

1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

1.4.3.1 China Market States and Outlook (2014-2024)

1.4.3.2 Japan Market States and Outlook (2014-2024)

1.4.3.3 Korea Market States and Outlook (2014-2024)

1.4.3.4 India Market States and Outlook (2014-2024)

1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)

1.4.4 South America, Middle East and Africa

1.4.4.1 Brazil Market States and Outlook (2014-2024)

1.4.4.2 Egypt Market States and Outlook (2014-2024)

1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)

1.4.4.4 South Africa Market States and Outlook (2014-2024)

1.4.4.5 Turkey Market States and Outlook (2014-2024)

1.5 Market Dynamics

1.5.1 Market Opportunities

1.5.2 Market Risk

1.5.3 Market Driving Force

2 Manufacturers Profiles

2.1 AbbVie Inc.

2.1.1 Business Overview

2.1.2 Anti-inflammatory Therapeutics Type and Applications

2.1.2.1 Product A

2.1.2.2 Product B

2.1.3 AbbVie Inc. Anti-inflammatory Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

2.2 Pfizer Inc.

2.2.1 Business Overview

2.2.2 Anti-inflammatory Therapeutics Type and Applications

2.2.2.1 Product A

2.2.2.2 Product B

2.2.3 Pfizer Inc. Anti-inflammatory Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

2.3 Merck & Co., Inc.

2.3.1 Business Overview

2.3.2 Anti-inflammatory Therapeutics Type and Applications

2.3.2.1 Product A

2.3.2.2 Product B

2.3.3 Merck & Co., Inc. Anti-inflammatory Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

2.4 Johnson & Johnson

2.4.1 Business Overview

2.4.2 Anti-inflammatory Therapeutics Type and Applications

2.4.2.1 Product A

2.4.2.2 Product B

2.4.3 Johnson & Johnson Anti-inflammatory Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

2.5 GlaxoSmithKline plc

2.5.1 Business Overview

2.5.2 Anti-inflammatory Therapeutics Type and Applications

2.5.2.1 Product A

2.5.2.2 Product B

2.5.3 GlaxoSmithKline plc Anti-inflammatory Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

2.6 AstraZeneca PLC

2.6.1 Business Overview

2.6.2 Anti-inflammatory Therapeutics Type and Applications

2.6.2.1 Product A

2.6.2.2 Product B

2.6.3 AstraZeneca PLC Anti-inflammatory Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

2.7 Amgen Inc

2.7.1 Business Overview

2.7.2 Anti-inflammatory Therapeutics Type and Applications

2.7.2.1 Product A

2.7.2.2 Product B

2.7.3 Amgen Inc Anti-inflammatory Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

2.8 Novartis AG

2.8.1 Business Overview

2.8.2 Anti-inflammatory Therapeutics Type and Applications

2.8.2.1 Product A

2.8.2.2 Product B

2.8.3 Novartis AG Anti-inflammatory Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

2.9 F. Hoffmann-La Roche AG

2.9.1 Business Overview

2.9.2 Anti-inflammatory Therapeutics Type and Applications

2.9.2.1 Product A

2.9.2.2 Product B

2.9.3 F. Hoffmann-La Roche AG Anti-inflammatory Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

2.10 Eli Lily and Company

2.10.1 Business Overview

2.10.2 Anti-inflammatory Therapeutics Type and Applications

2.10.2.1 Product A

2.10.2.2 Product B

2.10.3 Eli Lily and Company Anti-inflammatory Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

3 Global Anti-inflammatory Therapeutics Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)

3.1 Global Anti-inflammatory Therapeutics Sales and Market Share by Manufacturer (2017-2018)

3.2 Global Anti-inflammatory Therapeutics Revenue and Market Share by Manufacturer (2017-2018)

3.3 Market Concentration Rate

3.3.1 Top 3 Anti-inflammatory Therapeutics Manufacturer Market Share in 2018

3.3.2 Top 6 Anti-inflammatory Therapeutics Manufacturer Market Share in 2018

3.4 Market Competition Trend

4 Global Anti-inflammatory Therapeutics Market Analysis by Regions

4.1 Global Anti-inflammatory Therapeutics Sales, Revenue and Market Share by Regions

4.1.1 Global Anti-inflammatory Therapeutics Sales and Market Share by Regions (2014-2019)

4.1.2 Global Anti-inflammatory Therapeutics Revenue and Market Share by Regions (2014-2019)

4.2 North America Anti-inflammatory Therapeutics Sales and Growth Rate (2014-2019)

4.3 Europe Anti-inflammatory Therapeutics Sales and Growth Rate (2014-2019)

4.4 Asia-Pacific Anti-inflammatory Therapeutics Sales and Growth Rate (2014-2019)

4.5 South America Anti-inflammatory Therapeutics Sales and Growth Rate (2014-2019)

4.6 Middle East and Africa Anti-inflammatory Therapeutics Sales and Growth Rate (2014-2019)

5 North America Anti-inflammatory Therapeutics by Country

5.1 North America Anti-inflammatory Therapeutics Sales, Revenue and Market Share by Country

5.1.1 North America Anti-inflammatory Therapeutics Sales and Market Share by Country (2014-2019)

5.1.2 North America Anti-inflammatory Therapeutics Revenue and Market Share by Country (2014-2019)

5.2 United States Anti-inflammatory Therapeutics Sales and Growth Rate (2014-2019)

5.3 Canada Anti-inflammatory Therapeutics Sales and Growth Rate (2014-2019)

5.4 Mexico Anti-inflammatory Therapeutics Sales and Growth Rate (2014-2019)

6 Europe Anti-inflammatory Therapeutics by Country

6.1 Europe Anti-inflammatory Therapeutics Sales, Revenue and Market Share by Country

6.1.1 Europe Anti-inflammatory Therapeutics Sales and Market Share by Country (2014-2019)

6.1.2 Europe Anti-inflammatory Therapeutics Revenue and Market Share by Country (2014-2019)

6.2 Germany Anti-inflammatory Therapeutics Sales and Growth Rate (2014-2019)

6.3 UK Anti-inflammatory Therapeutics Sales and Growth Rate (2014-2019)

6.4 France Anti-inflammatory Therapeutics Sales and Growth Rate (2014-2019)

6.5 Russia Anti-inflammatory Therapeutics Sales and Growth Rate (2014-2019)

6.6 Italy Anti-inflammatory Therapeutics Sales and Growth Rate (2014-2019)

7 Asia-Pacific Anti-inflammatory Therapeutics by Country

7.1 Asia-Pacific Anti-inflammatory Therapeutics Sales, Revenue and Market Share by Country

7.1.1 Asia-Pacific Anti-inflammatory Therapeutics Sales and Market Share by Country (2014-2019)

7.1.2 Asia-Pacific Anti-inflammatory Therapeutics Revenue and Market Share by Country (2014-2019)

7.2 China Anti-inflammatory Therapeutics Sales and Growth Rate (2014-2019)

7.3 Japan Anti-inflammatory Therapeutics Sales and Growth Rate (2014-2019)

7.4 Korea Anti-inflammatory Therapeutics Sales and Growth Rate (2014-2019)

7.5 India Anti-inflammatory Therapeutics Sales and Growth Rate (2014-2019)

7.6 Southeast Asia Anti-inflammatory Therapeutics Sales and Growth Rate (2014-2019)

8 South America Anti-inflammatory Therapeutics by Country

8.1 South America Anti-inflammatory Therapeutics Sales, Revenue and Market Share by Country

8.1.1 South America Anti-inflammatory Therapeutics Sales and Market Share by Country (2014-2019)

8.1.2 South America Anti-inflammatory Therapeutics Revenue and Market Share by Country (2014-2019)

8.2 Brazil Anti-inflammatory Therapeutics Sales and Growth Rate (2014-2019)

8.3 Argentina Anti-inflammatory Therapeutics Sales and Growth Rate (2014-2019)

8.4 Colombia Anti-inflammatory Therapeutics Sales and Growth Rate (2014-2019)

9 Middle East and Africa Anti-inflammatory Therapeutics by Countries

9.1 Middle East and Africa Anti-inflammatory Therapeutics Sales, Revenue and Market Share by Country

9.1.1 Middle East and Africa Anti-inflammatory Therapeutics Sales and Market Share by Country (2014-2019)

9.1.2 Middle East and Africa Anti-inflammatory Therapeutics Revenue and Market Share by Country (2014-2019)

9.2 Saudi Arabia Anti-inflammatory Therapeutics Sales and Growth Rate (2014-2019)

9.3 Turkey Anti-inflammatory Therapeutics Sales and Growth Rate (2014-2019)

9.4 Egypt Anti-inflammatory Therapeutics Sales and Growth Rate (2014-2019)

9.5 Nigeria Anti-inflammatory Therapeutics Sales and Growth Rate (2014-2019)

9.6 South Africa Anti-inflammatory Therapeutics Sales and Growth Rate (2014-2019)

10 Global Anti-inflammatory Therapeutics Market Segment by Type

10.1 Global Anti-inflammatory Therapeutics Sales, Revenue and Market Share by Type (2014-2019)

10.1.1 Global Anti-inflammatory Therapeutics Sales and Market Share by Type (2014-2019)

10.1.2 Global Anti-inflammatory Therapeutics Revenue and Market Share by Type (2014-2019)

10.2 Nonsteroidal Anti-inflammatory Diseases (NSAIDs) Sales Growth and Price

10.2.1 Global Nonsteroidal Anti-inflammatory Diseases (NSAIDs) Sales Growth (2014-2019)

10.2.2 Global Nonsteroidal Anti-inflammatory Diseases (NSAIDs) Price (2014-2019)

10.3 Immune Selective Anti-inflammatory Derivatives (ImSAIDs) Sales Growth and Price

10.3.1 Global Immune Selective Anti-inflammatory Derivatives (ImSAIDs) Sales Growth (2014-2019)

10.3.2 Global Immune Selective Anti-inflammatory Derivatives (ImSAIDs) Price (2014-2019)

10.4 Corticosteroids Sales Growth and Price

10.4.1 Global Corticosteroids Sales Growth (2014-2019)

10.4.2 Global Corticosteroids Price (2014-2019)

10.5 Biologics Sales Growth and Price

10.5.1 Global Biologics Sales Growth (2014-2019)

10.5.2 Global Biologics Price (2014-2019)

11 Global Anti-inflammatory Therapeutics Market Segment by Application

11.1 Global Anti-inflammatory Therapeutics Sales Market Share by Application (2014-2019)

11.2 Arthritis Sales Growth (2014-2019)

11.3 Psoriasis Sales Growth (2014-2019)

11.4 Respiratory Disease Sales Growth (2014-2019)

11.5 Multiple Sclerosis Sales Growth (2014-2019)

11.6 Inflammatory Bowel Disease Sales Growth (2014-2019)

11.7 Other Inflammatory Disease Sales Growth (2014-2019)

12 Anti-inflammatory Therapeutics Market Forecast (2019-2024)

12.1 Global Anti-inflammatory Therapeutics Sales, Revenue and Growth Rate (2019-2024)

12.2 Anti-inflammatory Therapeutics Market Forecast by Regions (2019-2024)

12.2.1 North America Anti-inflammatory Therapeutics Market Forecast (2019-2024)

12.2.2 Europe Anti-inflammatory Therapeutics Market Forecast (2019-2024)

12.2.3 Asia-Pacific Anti-inflammatory Therapeutics Market Forecast (2019-2024)

12.2.4 South America Anti-inflammatory Therapeutics Market Forecast (2019-2024)

12.2.5 Middle East and Africa Anti-inflammatory Therapeutics Market Forecast (2019-2024)

12.3 Anti-inflammatory Therapeutics Market Forecast by Type (2019-2024)

12.3.1 Global Anti-inflammatory Therapeutics Sales Forecast by Type (2019-2024)

12.3.2 Global Anti-inflammatory Therapeutics Market Share Forecast by Type (2019-2024)

12.4 Anti-inflammatory Therapeutics Market Forecast by Application (2019-2024)

12.4.1 Global Anti-inflammatory Therapeutics Sales Forecast by Application (2019-2024)

12.4.2 Global Anti-inflammatory Therapeutics Market Share Forecast by Application (2019-2024)

13 Sales Channel, Distributors, Traders and Dealers

13.1 Sales Channel

13.1.1 Direct Marketing

13.1.2 Indirect Marketing

13.1.3 Marketing Channel Future Trend

13.2 Distributors, Traders and Dealers

14 Research Findings and Conclusion

15 Appendix

15.1 Methodology

15.2 Data Source

List of Tables and Figures

Figure Anti-inflammatory Therapeutics Picture

Table Product Specifications of Anti-inflammatory Therapeutics

Figure Global Sales Market Share of Anti-inflammatory Therapeut